共 50 条
- [2] Ustekinumab in Patients with Active Psoriatic Arthritis: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Psummit I Study ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1083 - S1084
- [5] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 1 Year Results of the Phase 3, Multicentre, Double-Blind, Placebo-Controlled PSUMMIT 1 Trial JOURNAL FUR MINERALSTOFFWECHSEL, 2013, 20 (04): : 175 - 176
- [8] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3323 - 3324
- [10] Ustekinumab in Active Psoriatic Arthritis Including Patients Previously Treated with Anti-TNF Agents: Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1080 - S1081